Copied to clipboard!
Whole-exome sequencing data from a phase 2 trial of dasatinib for patients with relapsed or refractory nodal T follicular helper cell lymphomas
Whole-exome sequencing (WES) analysis data from tumor tissues of 14 patients with T follicular helper cell lymphomas enrolled in a phase 2 trial of dasatinib for relapsed or refractory nodal disease.
- Type: Exome Sequencing
- Archive: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000001765 | HiSeq X Ten | 14 |
